These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32884143)

  • 1. India will supply coronavirus vaccines to the world - will its people benefit?
    Vaidyanathan G
    Nature; 2020 Sep; 585(7824):167-168. PubMed ID: 32884143
    [No Abstract]   [Full Text] [Related]  

  • 2. The unequal scramble for coronavirus vaccines - by the numbers.
    Callaway E
    Nature; 2020 Aug; 584(7822):506-507. PubMed ID: 32839593
    [No Abstract]   [Full Text] [Related]  

  • 3. Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access.
    Phelan AL; Eccleston-Turner M; Rourke M; Maleche A; Wang C
    Lancet; 2020 Sep; 396(10254):800-802. PubMed ID: 32910908
    [No Abstract]   [Full Text] [Related]  

  • 4. Back to the future.
    Offit P
    Expert Rev Vaccines; 2004 Apr; 3(2):107-8. PubMed ID: 15056035
    [No Abstract]   [Full Text] [Related]  

  • 5. Conference report - global vaccines - what are the challenges? Highlights from the Viral Vaccine Meeting; October 25-28, 2003; Barcelona, Spain.
    Armandola E
    MedGenMed; 2003 Dec; 5(4):29. PubMed ID: 14745376
    [No Abstract]   [Full Text] [Related]  

  • 6. The fight to manufacture COVID vaccines in lower-income countries.
    Maxmen A
    Nature; 2021 Sep; 597(7877):455-457. PubMed ID: 34526695
    [No Abstract]   [Full Text] [Related]  

  • 7. Licensing IP to ensure accessibility to vaccines and other immunisation-related products.
    Mehta JM
    Vaccine; 2001 Feb; 19(13-14):1581-7; discussion 1592-3. PubMed ID: 11166878
    [No Abstract]   [Full Text] [Related]  

  • 8. The global capacity for manufacturing vaccines. Prospects for competition and collaboration among producers in the next decade.
    Robbins A; Arita I
    Int J Technol Assess Health Care; 1994; 10(1):39-46. PubMed ID: 8157459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global health system: linking knowledge with action--learning from malaria.
    Keusch GT; Kilama WL; Moon S; Szlezák NA; Michaud CM
    PLoS Med; 2010 Jan; 7(1):e1000179. PubMed ID: 20087415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Getting an AIDS vaccine to the developing world.
    Rhein R
    BMJ; 1990 Oct; 301(6755):778-9. PubMed ID: 2224264
    [No Abstract]   [Full Text] [Related]  

  • 11. India's science test.
    Padma TV
    Nature; 2015 May; 521(7551):144-7. PubMed ID: 25971492
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 vaccine affordability and accessibility.
    Karim SA
    Lancet; 2020 Jul; 396(10246):238. PubMed ID: 32711799
    [No Abstract]   [Full Text] [Related]  

  • 13. [TBE vaccines--safety and efficiency at any cost].
    Wahlberg T
    Lakartidningen; 1999 Mar; 96(12):1425. PubMed ID: 10222700
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth of the Asian health-care market: global implications for the pharmaceutical industry.
    Epstein RJ
    Nat Rev Drug Discov; 2007 Oct; 6(10):785-92. PubMed ID: 17853900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An industry update: the latest developments in therapeutic delivery covering May 2020.
    Steinbach OC
    Ther Deliv; 2020 Sep; 11(9):541-546. PubMed ID: 32840177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. India: 50 years after independence.
    Miller DD; Nayak AR
    Nat Biotechnol; 1997 Aug; 15(8):727-9. PubMed ID: 9255782
    [No Abstract]   [Full Text] [Related]  

  • 17. Indian-born weapons for infectious diseases.
    Padmanaban G
    Nat Med; 2003 Jul; 9(7):813. PubMed ID: 12835687
    [No Abstract]   [Full Text] [Related]  

  • 18. Increase in R&D openness to tackle disease in the developing world.
    Parks L
    Future Med Chem; 2012 Dec; 4(18):2237. PubMed ID: 23234547
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronavirus shuts down trials of drugs for multiple other diseases.
    Ledford H
    Nature; 2020 Apr; 580(7801):15-16. PubMed ID: 32214240
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccine campaign to target deadly childhood diarrhoea.
    Butler D
    Nature; 2011 Sep; 477(7366):519. PubMed ID: 21956306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.